NBS Plus 8P with HB Variant Analysis

This is a specialized newborn screening panel that includes analysis of chromosomal abnormalities on the short arm of chromosome 8 (8p) along with screening for Hemoglobin (H) variant disorders. It is designed to detect both genetic syndromes associated with 8p deletions or duplications and hemoglobinopathies such as sickle cell disease and thalassemias early in life.

Early identification of chromosomal anomalies and hemoglobin disorders allows for timely intervention and management. Conditions associated with 8p abnormalities can involve developmental delays, cardiac defects, and neurological impairments. Likewise, detecting H variant hemoglobinopathies helps initiate treatments that prevent complications like anemia, infections, or organ damage.

 It is typically performed as part of extended newborn screening shortly after birth—usually within the first few days of life—using a dried blood spot sample collected via heel prick. If abnormalities are found, further confirmatory genetic and clinical evaluations are recommended.

A positive result for 8p variants suggests the need for detailed genetic counseling and further cytogenetic or FISH analysis. Hemoglobin H disease detection prompts a referral to a pediatric hematologist for ongoing monitoring and care. A negative result usually indicates that the baby is not at risk for the screened conditions.

Yes, abnormal results are followed up with additional genetic testing, such as chromosomal microarray or targeted gene sequencing, along with clinical assessments and specialist referrals to guide treatment and supportive care.